Product description

The active substance in Almirid-Cripar is the hydrogenated ergot alkaloid a-dihy­droergocryptine methane sulfonate, which has high affinity for dopamine receptors. alpha-Dihydroergocryptine methane sulfonate is a selective D2 receptor agonist and a partial D1 receptor agonist, and in vivo it has no activity on serotonergic or adre­nergic receptors.


For the treatment of shaking palsy (idiopathic Parkinson’s disease) in patients without fluctuations in their clinical picture, either as monotherapy or in combination with levodopa (with or without a decarboxylase inhibitor).